{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T08:27:29Z","timestamp":1792744049624,"version":"4.5.0"},"reference-count":132,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020166","name":"Flu Lab LLC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.atherosclerosis.2025.120405","type":"journal-article","created":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T11:07:24Z","timestamp":1749812844000},"page":"120405","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["The flu shot and cardiovascular Protection: Rethinking inflammation in ischemic heart disease"],"prefix":"10.1016","volume":"414","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5846-345X","authenticated-orcid":false,"given":"Ole","family":"Fr\u00f6bert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida B.","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid J.","family":"Hjelholt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Erikstrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Cajander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.atherosclerosis.2025.120405_bib1","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.chom.2020.03.009","article-title":"Human influenza virus hemagglutinins contain conserved oligomannose N-Linked glycans allowing potent neutralization by lectins","volume":"27","author":"Thompson","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"175","key":"10.1016\/j.atherosclerosis.2025.120405_bib2","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0144-2024","article-title":"Influenza vaccine outcomes: a meta-analysis revealing morbidity benefits amid low infection prevention","volume":"34","author":"Presa","year":"2025","journal-title":"Eur Respir Rev"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120405_bib3","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1128\/mr.56.1.152-179.1992","article-title":"Evolution and ecology of influenza A viruses","volume":"56","author":"Webster","year":"1992","journal-title":"Microbiol Rev"},{"key":"10.1016\/j.atherosclerosis.2025.120405_bib4","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.biochem.69.1.531","article-title":"Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin","volume":"69","author":"Skehel","year":"2000","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.atherosclerosis.2025.120405_bib5","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.2307\/4580606","article-title":"Excess mortality from causes other than influenza and pneumonia during influenza epidemic","volume":"47","author":"Collins","year":"1932","journal-title":"Publ Health Rep"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120405_bib6","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/oxfordjournals.aje.a112007","article-title":"Excess mortality from epidemic influenza, 1957-1966","volume":"100","author":"Housworth","year":"1974","journal-title":"Am J Epidemiol"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2025.120405_bib7","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/eurjpc\/zwae016","article-title":"Association of respiratory infections and the impact of vaccinations on cardiovascular diseases","volume":"31","author":"Rademacher","year":"2024","journal-title":"Eur J Prev Cardiol"},{"issue":"Suppl 1","key":"10.1016\/j.atherosclerosis.2025.120405_bib8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s40121-024-01080-4","article-title":"Burden of acute respiratory infections caused by influenza virus, respiratory syncytial virus, and SARS-CoV-2 with consideration of older adults: a narrative review","volume":"14","author":"Hanage","year":"2025","journal-title":"Infect Dis Ther"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2025.120405_bib9","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01794-2017","article-title":"Laboratory-confirmed respiratory infections as triggers for acute myocardial infarction and stroke: a self-controlled case series analysis of national linked datasets from Scotland","volume":"51","author":"Warren-Gash","year":"2018","journal-title":"Eur Respir J"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2025.120405_bib10","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1093\/infdis\/jis597","article-title":"Influenza infection and risk of acute myocardial infarction in England and Wales: a CALIBER self-controlled case series study","volume":"206","author":"Warren-Gash","year":"2012","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2025.120405_bib11","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1056\/NEJMoa1702090","article-title":"Acute myocardial infarction after laboratory-confirmed influenza infection","volume":"378","author":"Kwong","year":"2018","journal-title":"N Engl J Med"},{"issue":"Suppl A","key":"10.1016\/j.atherosclerosis.2025.120405_bib12","doi-asserted-by":"crossref","first-page":"A42","DOI":"10.1093\/eurheartjsupp\/suac123","article-title":"The impact of COVID-19 and COVID vaccination on cardiovascular outcomes","volume":"25","author":"Akhtar","year":"2023","journal-title":"Eur Heart J Suppl"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2025.120405_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0236866","article-title":"Association of acute myocardial infarction with influenza: a nationwide observational study","volume":"15","author":"Mohammad","year":"2020","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2025.120405_bib14","doi-asserted-by":"crossref","first-page":"e722","DOI":"10.1093\/infdis\/jiae070","article-title":"Risk of cardiovascular events after influenza: a population-based self-controlled case series study, Spain, 2011-2018","volume":"230","author":"Munoz-Quiles","year":"2024","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2025.120405_bib15","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1001\/jamacardio.2016.0433","article-title":"Seasonal influenza infections and cardiovascular disease mortality","volume":"1","author":"Nguyen","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.atherosclerosis.2025.120405_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.thromres.2024.109213","article-title":"Risks of major arterial and venous thrombotic diseases after hospitalisation for influenza, pneumonia, and COVID-19: a population-wide cohort in 2.6 million people in Wales","volume":"245","author":"Keene","year":"2025","journal-title":"Thromb Res"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2025.120405_bib17","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1093\/infdis\/jir171","article-title":"Circulating influenza virus, climatic factors, and acute myocardial infarction: a time series study in England and Wales and Hong Kong","volume":"203","author":"Warren-Gash","year":"2011","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2025.120405_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-002604","article-title":"Influenza-like illness in acute myocardial infarction patients during the winter wave of the influenza A H1N1 pandemic in London: a case-control study","volume":"3","author":"Warren-Gash","year":"2013","journal-title":"BMJ Open"},{"issue":"21","key":"10.1016\/j.atherosclerosis.2025.120405_bib19","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1136\/heartjnl-2015-307691","article-title":"Acute myocardial infarction and influenza: a meta-analysis of case-control studies","volume":"101","author":"Barnes","year":"2015","journal-title":"Heart"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2025.120405_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0272661","article-title":"Early risk of acute myocardial infarction following hospitalization for severe influenza infection in the middle-aged population of Hong Kong","volume":"17","author":"Cheng","year":"2022","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2025.120405_bib21","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2300361","article-title":"Influenza infection and acute myocardial infarction","volume":"3","author":"de Boer","year":"2024","journal-title":"NEJM Evid"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2025.120405_bib22","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019608","article-title":"Relationship between influenza, temperature, and type 1 myocardial infarction: an ecological time-series study","volume":"10","author":"Garcia-Lledo","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"Suppl 1","key":"10.1016\/j.atherosclerosis.2025.120405_bib23","doi-asserted-by":"crossref","first-page":"A6","DOI":"10.1016\/j.vaccine.2020.09.048","article-title":"The disease burden of influenza beyond respiratory illness","volume":"39","author":"Macias","year":"2021","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2025.120405_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0243248","article-title":"Laboratory-confirmed influenza infection and acute myocardial infarction among United States senior Veterans","volume":"15","author":"Young-Xu","year":"2020","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2025.120405_bib25","doi-asserted-by":"crossref","first-page":"605","DOI":"10.7326\/M20-1509","article-title":"Acute cardiovascular events associated with influenza in hospitalized adults : a cross-sectional study","volume":"173","author":"Chow","year":"2020","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2025.120405_bib26","doi-asserted-by":"crossref","DOI":"10.1093\/ehjopen\/oeac051","article-title":"Prevalence and prognostic implications of myocardial injury in patients with influenza","volume":"2","author":"Nordenskjold","year":"2022","journal-title":"Eur Heart J Open"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.120405_bib27","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jchf.2018.10.011","article-title":"Effect of influenza on outcomes in patients with heart failure","volume":"7","author":"Panhwar","year":"2019","journal-title":"JACC Heart Fail"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.120405_bib28","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/ejhf.901","article-title":"Prevalence and prognostic importance of precipitating factors leading to heart failure hospitalization: recurrent hospitalizations and mortality","volume":"20","author":"Platz","year":"2018","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.120405_bib29","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/ejhf.682","article-title":"Precipitating factors and 90-day outcome of acute heart failure: a report from the intercontinental GREAT registry","volume":"19","author":"Arrigo","year":"2017","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2025.120405_bib30","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1007\/s10653-019-00265-y","article-title":"Seasonal variation in the occurrence of ischemic stroke: a meta-analysis","volume":"41","author":"Li","year":"2019","journal-title":"Environ Geochem Health"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2025.120405_bib31","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/acn3.545","article-title":"Influenza-like illness as a trigger for ischemic stroke","volume":"5","author":"Boehme","year":"2018","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120405_bib32","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1186\/s12889-021-10916-4","article-title":"Risk of stroke and myocardial infarction after influenza-like illness in New York state","volume":"21","author":"Kulick","year":"2021","journal-title":"BMC Public Health"},{"issue":"25","key":"10.1016\/j.atherosclerosis.2025.120405_bib33","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1056\/NEJMoa041747","article-title":"Risk of myocardial infarction and stroke after acute infection or vaccination","volume":"351","author":"Smeeth","year":"2004","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2025.120405_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/v14122817","article-title":"Thromboembolic events in patients with influenza: a scoping review","volume":"14","author":"Rubino","year":"2022","journal-title":"Viruses"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2025.120405_bib35","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.2022.13072","article-title":"Association of COVID-19 vs influenza with risk of arterial and venous thrombotic events among hospitalized patients","volume":"328","author":"Lo Re","year":"2022","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2025.120405_bib36","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.hrthm.2016.01.026","article-title":"The association between influenza infection, vaccination, and atrial fibrillation: a nationwide case-control study","volume":"13","author":"Chang","year":"2016","journal-title":"Heart Rhythm"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2025.120405_bib37","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/cvr\/cvaa117","article-title":"Human influenza A virus causes myocardial and cardiac-specific conduction system infections associated with early inflammation and premature death","volume":"117","author":"Filgueiras-Rama","year":"2021","journal-title":"Cardiovasc Res"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2025.120405_bib38","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1007\/s10840-023-01525-9","article-title":"Cardiac arrhythmias in viral infections","volume":"66","author":"Lee","year":"2023","journal-title":"J Intervent Card Electrophysiol"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2025.120405_bib39","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1253\/circj.CJ-10-0452","article-title":"Clinical research committee on myocarditis associated with influenza APiJobJCS. A national survey on myocarditis associated with the 2009 influenza A (H1N1) pandemic in Japan","volume":"74","author":"Ukimura","year":"2010","journal-title":"Circ J"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2025.120405_bib40","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s15010-016-0892-0","article-title":"Transitory ventricular tachycardia associated with influenza A infection of cardiac conduction tissue","volume":"44","author":"Frustaci","year":"2016","journal-title":"Infection"},{"issue":"24","key":"10.1016\/j.atherosclerosis.2025.120405_bib41","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1136\/heartjnl-2016-309983","article-title":"Influenza vaccine as a coronary intervention for prevention of myocardial infarction","volume":"102","author":"MacIntyre","year":"2016","journal-title":"Heart"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.120405_bib42","doi-asserted-by":"crossref","first-page":"540","DOI":"10.4049\/jimmunol.0903395","article-title":"Cutting edge: sympathetic nervous system increases proinflammatory cytokines and exacerbates influenza A virus pathogenesis","volume":"184","author":"Grebe","year":"2010","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120405_bib43","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1128\/MMBR.05015-11","article-title":"Into the eye of the cytokine storm","volume":"76","author":"Tisoncik","year":"2012","journal-title":"Microbiol Mol Biol Rev"},{"issue":"9348","key":"10.1016\/j.atherosclerosis.2025.120405_bib44","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/S0140-6736(02)11772-7","article-title":"Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?","volume":"360","author":"Cheung","year":"2002","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2025.120405_bib45","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nri3665","article-title":"Innate immunity to influenza virus infection","volume":"14","author":"Iwasaki","year":"2014","journal-title":"Nat Rev Immunol"},{"issue":"21","key":"10.1016\/j.atherosclerosis.2025.120405_bib46","doi-asserted-by":"crossref","first-page":"11515","DOI":"10.1128\/JVI.01703-09","article-title":"Lambda interferon is the predominant interferon induced by influenza A virus infection in vivo","volume":"84","author":"Jewell","year":"2010","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2025.120405_bib47","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.immuni.2009.02.005","article-title":"The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA","volume":"30","author":"Allen","year":"2009","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120405_bib48","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00705-003-0208-4","article-title":"Induction of interferon-inducible protein-10 and monokine induced by interferon-gamma from human endothelial cells infected with influenza A virus","volume":"149","author":"Ishiguro","year":"2004","journal-title":"Arch Virol"},{"key":"10.1016\/j.atherosclerosis.2025.120405_bib49","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.virol.2015.03.037","article-title":"Transcriptional response of human umbilical vein endothelial cell to H9N2 influenza virus infection","volume":"482","author":"Wang","year":"2015","journal-title":"Virology"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2025.120405_bib50","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1002\/jmv.24166","article-title":"Influenza virus aggravates the ox-LDL-induced apoptosis of human endothelial cells via promoting p53 signaling","volume":"87","author":"Suo","year":"2015","journal-title":"J Med Virol"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.120405_bib51","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/infdis\/jiz580","article-title":"Matrix Metalloproteinase-13 in atherosclerotic plaque is increased by influenza A virus infection","volume":"221","author":"Lee","year":"2020","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120405_bib52","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.atherosclerosis.2009.07.028","article-title":"Influenza virus directly infects, inflames, and resides in the arteries of atherosclerotic and normal mice","volume":"208","author":"Haidari","year":"2010","journal-title":"Atherosclerosis"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2025.120405_bib53","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1161\/01.RES.0000250834.29108.1a","article-title":"Effects on coagulation and fibrinolysis induced by influenza in mice with a reduced capacity to generate activated protein C and a deficiency in plasminogen activator inhibitor type 1","volume":"99","author":"Keller","year":"2006","journal-title":"Circ Res"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2025.120405_bib54","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1093\/infdis\/jix475","article-title":"High level of neutrophil extracellular traps correlates with poor prognosis of severe influenza A infection","volume":"217","author":"Zhu","year":"2018","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2025.120405_bib55","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019636","article-title":"Effects of influenza vaccine on mortality and cardiovascular outcomes in patients with cardiovascular disease: a systematic review and meta-analysis","volume":"10","author":"Yedlapati","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"14","key":"10.1016\/j.atherosclerosis.2025.120405_bib56","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1093\/eurjpc\/zwac152","article-title":"Cardioprotective effects of influenza vaccination among patients with established cardiovascular disease or at high cardiovascular risk: a systematic review and meta-analysis","volume":"29","author":"Jaiswal","year":"2022","journal-title":"Eur J Prev Cardiol"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2025.120405_bib57","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1080\/14760584.2019.1690459","article-title":"The association of influenza infection and vaccine with myocardial infarction: systematic review and meta-analysis of self-controlled case series","volume":"18","author":"Caldeira","year":"2019","journal-title":"Expert Rev Vaccines"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2025.120405_bib58","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.vaccine.2010.12.017","article-title":"The effect of influenza vaccination on risk of acute myocardial infarction: self-controlled case-series study","volume":"29","author":"Gwini","year":"2011","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2025.120405_bib59","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/eurheartj\/ehac737","article-title":"Primary prevention of acute cardiovascular events by influenza vaccination: an observational study","volume":"44","author":"Davidson","year":"2023","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120405_bib60","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12872-020-01836-z","article-title":"Influenza vaccination and risk for cardiovascular events: a nationwide self-controlled case series study","volume":"21","author":"Sen","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.atherosclerosis.2025.120405_bib61","series-title":"Seasonal influenza vaccination recommendations and coverage rates in EU\/EEA member states \u2013 an overview of vaccination recommendations for vaccination recommendations for 2021-22 and coverage rates for the 2018\u201319 to 2020\u201321 influenza seasons","year":"2023"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.120405_bib62","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200206","article-title":"A pragmatic randomized feasibility trial of influenza vaccines","volume":"2","author":"Johansen","year":"2023","journal-title":"NEJM Evid"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.120405_bib63","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.124.011496","article-title":"Relative effectiveness of high-dose versus standard-dose quadrivalent influenza vaccine in older adults with cardiovascular disease: a prespecified analysis of the DANFLU-1 randomized clinical trial","volume":"18","author":"Christensen","year":"2025","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120405_bib64","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/jama.2020.23649","article-title":"Effect of high-dose trivalent vs standard-dose quadrivalent influenza vaccine on mortality or cardiopulmonary hospitalization in patients with high-risk cardiovascular disease: a randomized clinical trial","volume":"325","author":"Vardeny","year":"2021","journal-title":"JAMA"},{"issue":"41","key":"10.1016\/j.atherosclerosis.2025.120405_bib65","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.1093\/eurheartj\/ehac472","article-title":"Influenza vaccination strategy in acute coronary syndromes: the VIP-ACS trial","volume":"43","author":"Fonseca","year":"2022","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120405_bib66","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ehj.2003.10.018","article-title":"Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) study","volume":"25","author":"Gurfinkel","year":"2004","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2025.120405_bib67","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1093\/eurheartj\/ehm581","article-title":"Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study","volume":"29","author":"Ciszewski","year":"2008","journal-title":"Eur Heart J"},{"issue":"14","key":"10.1016\/j.atherosclerosis.2025.120405_bib68","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1093\/eurheartj\/ehr004","article-title":"Influenza vaccination reduces cardiovascular events in patients with acute coronary syndrome","volume":"32","author":"Phrommintikul","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2025.120405_bib69","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.121.057042","article-title":"Influenza vaccination after myocardial infarction: a randomized, double-blind, placebo-controlled, multicenter trial","author":"Frobert","year":"2021","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2025.120405_bib70","doi-asserted-by":"crossref","first-page":"e1835","DOI":"10.1016\/S2214-109X(22)00432-6","article-title":"Influenza vaccine to reduce adverse vascular events in patients with heart failure: a multinational randomised, double-blind, placebo-controlled trial","volume":"10","author":"Loeb","year":"2022","journal-title":"Lancet Glob Health"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2025.120405_bib71","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.8873","article-title":"Association of influenza vaccination with cardiovascular risk: a meta-analysis","volume":"5","author":"Behrouzi","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"5\u20136","key":"10.1016\/j.atherosclerosis.2025.120405_bib72","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0928-0197(94)90057-4","article-title":"Early kinetics of antibody response to inactivated influenza vaccine","volume":"1","author":"Pyhala","year":"1994","journal-title":"Clin Diagn Virol"},{"issue":"48","key":"10.1016\/j.atherosclerosis.2025.120405_bib73","doi-asserted-by":"crossref","first-page":"7159","DOI":"10.1016\/j.vaccine.2023.10.028","article-title":"Optimal timing of influenza vaccination among patients with acute myocardial infarction - findings from the IAMI trial","volume":"41","author":"Akhtar","year":"2023","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120405_bib74","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2100009","article-title":"Regulatory T-Cell response to low-dose Interleukin-2 in ischemic heart disease","volume":"1","author":"Zhao","year":"2022","journal-title":"NEJM Evidence"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2025.120405_bib75","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.vaccine.2005.09.058","article-title":"Age-related changes in the immune response to influenza vaccination in a racially diverse, healthy elderly population","volume":"24","author":"Gardner","year":"2006","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2025.120405_bib76","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/j.athoracsur.2020.07.052","article-title":"Influenza vaccination blunts the inflammatory response in patients undergoing cardiopulmonary bypass","volume":"111","author":"Atoui","year":"2021","journal-title":"Ann Thorac Surg"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2025.120405_bib77","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009928","article-title":"Induction of trained immunity by influenza vaccination - impact on COVID-19","volume":"17","author":"Debisarun","year":"2021","journal-title":"PLoS Pathog"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120405_bib78","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1161\/CIRCRESAHA.115.303895","article-title":"Foxp3+ CD4+ T cells improve healing after myocardial infarction by modulating monocyte\/macrophage differentiation","volume":"115","author":"Weirather","year":"2014","journal-title":"Circ Res"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.120405_bib79","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/eurheartj\/ehad486","article-title":"Inflammation in acute myocardial infarction: the good, the bad and the ugly","volume":"45","author":"Matter","year":"2024","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2025.120405_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2016.12.018","article-title":"Foxp3 reprograms T cell metabolism to function in low-glucose, high-lactate environments","volume":"25","author":"Angelin","year":"2017","journal-title":"Cell Metab"},{"key":"10.1016\/j.atherosclerosis.2025.120405_bib81","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15781","article-title":"Type-2 innate lymphoid cells control the development of atherosclerosis in mice","volume":"8","author":"Newland","year":"2017","journal-title":"Nat Commun"},{"issue":"6\u20137","key":"10.1016\/j.atherosclerosis.2025.120405_bib82","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.acvd.2022.01.005","article-title":"Does the influenza A vaccine have a direct atheroprotective effect?","volume":"115","author":"Aidoud","year":"2022","journal-title":"Arch Cardiovasc Dis"},{"issue":"48","key":"10.1016\/j.atherosclerosis.2025.120405_bib83","doi-asserted-by":"crossref","first-page":"6569","DOI":"10.1016\/j.vaccine.2014.07.007","article-title":"Influenza vaccine as prevention for cardiovascular diseases: possible molecular mechanism","volume":"32","author":"Veljkovic","year":"2014","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2025.120405_bib84","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41569-024-01111-0","article-title":"Apolipoprotein B-containing lipoproteins in atherogenesis","volume":"22","author":"Boren","year":"2025","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120405_bib85","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/bmb\/ldab027","article-title":"Immunotherapy for type 1 diabetes","volume":"140","author":"Allen","year":"2021","journal-title":"Br Med Bull"},{"issue":"6554","key":"10.1016\/j.atherosclerosis.2025.120405_bib86","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1126\/science.abh1654","article-title":"Immunotherapy: building a bridge to a cure for type 1 diabetes","volume":"373","author":"Bluestone","year":"2021","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120405_bib87","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00125-017-4448-3","article-title":"Pandemrix(R) vaccination is not associated with increased risk of islet autoimmunity or type 1 diabetes in the TEDDY study children","volume":"61","author":"Elding","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.atherosclerosis.2025.120405_bib88","article-title":"Influenza vaccination blunts the inflammatory response in patients undergoing cardiopulmonary bypass","author":"Atoui","year":"2020","journal-title":"Ann Thorac Surg"},{"issue":"15","key":"10.1016\/j.atherosclerosis.2025.120405_bib89","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1016\/j.cell.2021.05.039","article-title":"The single-cell epigenomic and transcriptional landscape of immunity to influenza vaccination","volume":"184","author":"Wimmers","year":"2021","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2025.120405_bib90","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-084808","article-title":"INfluenza VaccInation to mitigate typE 1 diabetes (INVITED): a study protocol for a randomised, double-blind, placebo-controlled clinical trial in children and adolescents with recent-onset type 1 diabetes","volume":"14","author":"Pedersen","year":"2024","journal-title":"BMJ Open"},{"issue":"47","key":"10.1016\/j.atherosclerosis.2025.120405_bib91","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000018035","article-title":"Effect of annual influenza vaccination on reducing lung cancer in patients with chronic obstructive pulmonary disease from a population-based cohort study","volume":"98","author":"Chen","year":"2019","journal-title":"Medicine (Baltim)"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2025.120405_bib92","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14122926","article-title":"Influenza vaccination and risk of lung cancer in patients with chronic kidney disease: a nationwide, population-based cohort study","volume":"14","author":"Chen","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2025.120405_bib93","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1002\/ijc.33340","article-title":"Association of postoperative influenza vaccine on overall mortality in patients undergoing curative surgery for solid tumors","volume":"148","author":"Gogenur","year":"2021","journal-title":"Int J Cancer"},{"key":"10.1016\/j.atherosclerosis.2025.120405_bib94","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.688755","article-title":"Repurposing infectious diseases vaccines against cancer","volume":"11","author":"Vandeborne","year":"2021","journal-title":"Front Oncol"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2025.120405_bib95","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.trecan.2021.02.006","article-title":"To vaccinate or not: influenza virus and lung cancer progression","volume":"7","author":"Angrini","year":"2021","journal-title":"Trends Cancer"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.120405_bib96","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/cid\/ciz202","article-title":"Safety of inactivated influenza vaccine in cancer patients receiving immune checkpoint inhibitors","volume":"70","author":"Chong","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2025.120405_bib97","doi-asserted-by":"crossref","first-page":"e573","DOI":"10.1200\/JOP.19.00495","article-title":"Safety of influenza vaccine in patients with cancer receiving pembrolizumab","volume":"16","author":"Failing","year":"2020","journal-title":"JCO Oncol Pract"},{"issue":"14","key":"10.1016\/j.atherosclerosis.2025.120405_bib98","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.2217\/imt-2018-0080","article-title":"INfluenza vaccine indication during therapy with immune checkpoint inhibitors: a transversal challenge. The INVIDIa study","volume":"10","author":"Bersanelli","year":"2018","journal-title":"Immunotherapy"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.120405_bib99","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2217\/imt-2019-0180","article-title":"Impact of influenza syndrome and flu vaccine on survival of cancer patients during immunotherapy in the INVIDIa study","volume":"12","author":"Bersanelli","year":"2020","journal-title":"Immunotherapy"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.120405_bib100","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1073\/pnas.1904022116","article-title":"Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer","volume":"117","author":"Newman","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"18","key":"10.1016\/j.atherosclerosis.2025.120405_bib101","doi-asserted-by":"crossref","first-page":"5104","DOI":"10.1158\/1078-0432.CCR-13-0246","article-title":"Perioperative influenza vaccination reduces postoperative metastatic disease by reversing surgery-induced dysfunction in natural killer cells","volume":"19","author":"Tai","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2025.120405_bib102","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1431082","article-title":"Phosphodiesterase-5 inhibition reduces postoperative metastatic disease by targeting surgery-induced myeloid derived suppressor cell-dependent inhibition of natural killer cell cytotoxicity","volume":"7","author":"Tai","year":"2018","journal-title":"OncoImmunology"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2025.120405_bib103","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.3233\/JAD-220361","article-title":"Risk of alzheimer's disease following influenza vaccination: a claims-based cohort study using propensity score matching","volume":"88","author":"Bukhbinder","year":"2022","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.atherosclerosis.2025.120405_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101534","article-title":"Influenza vaccination reduces dementia risk: a systematic review and meta-analysis","volume":"73","author":"Veronese","year":"2022","journal-title":"Ageing Res Rev"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2025.120405_bib105","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002868","article-title":"Influenza vaccination reduces dementia risk in chronic kidney disease patients: a population-based cohort study","volume":"95","author":"Liu","year":"2016","journal-title":"Medicine (Baltim)"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2025.120405_bib106","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1136\/jim-2019-001155","article-title":"Influenza vaccination reduces dementia in patients with chronic obstructive pulmonary disease: a nationwide cohort study","volume":"68","author":"Luo","year":"2020","journal-title":"J Investig Med"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2025.120405_bib107","first-page":"1495","article-title":"Past exposure to vaccines and subsequent risk of alzheimer's disease","volume":"165","author":"Verreault","year":"2001","journal-title":"CMAJ"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120405_bib108","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12974-020-01741-4","article-title":"Influenza vaccination in early alzheimer's disease rescues amyloidosis and ameliorates cognitive deficits in APP\/PS1 mice by inhibiting regulatory T cells","volume":"17","author":"Yang","year":"2020","journal-title":"J Neuroinflammation"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2025.120405_bib109","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a038489","article-title":"The ecology and evolution of influenza viruses","volume":"10","author":"Wille","year":"2020","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2025.120405_bib110","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/oxfordjournals.molbev.a004105","article-title":"Origin and evolution of influenza virus hemagglutinin genes","volume":"19","author":"Suzuki","year":"2002","journal-title":"Mol Biol Evol"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2025.120405_bib111","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jcmg.2011.02.002","article-title":"Atherosclerosis in ancient Egyptian mummies: the horus study","volume":"4","author":"Allam","year":"2011","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.atherosclerosis.2025.120405_bib112","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ijpp.2014.03.003","article-title":"Calcified structures associated with human skeletal remains: possible atherosclerosis affecting the population buried at amara West, Sudan (1300-800BC)","volume":"6","author":"Binder","year":"2014","journal-title":"Int J Paleopathol"},{"key":"10.1016\/j.atherosclerosis.2025.120405_bib113","first-page":"319","article-title":"Microscopic sections of the aorta of king merneptah","volume":"1","year":"1909","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2025.120405_bib114","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/1471-2350-12-160","article-title":"Antagonistic pleiotropy as a widespread mechanism for the maintenance of polymorphic disease alleles","volume":"12","author":"Carter","year":"2011","journal-title":"BMC Med Genet"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120405_bib115","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.atherosclerosis.2012.04.021","article-title":"Apo E4 and lipoprotein-associated phospholipase A2 synergistically increase cardiovascular risk","volume":"223","author":"Gungor","year":"2012","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120405_bib116","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jaci.2014.01.032","article-title":"APOepsilon4 is associated with enhanced in vivo innate immune responses in human subjects","volume":"134","author":"Gale","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2025.120405_bib117","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007390","article-title":"Toll-like receptor 4 in acute viral infection: too much of a good thing","volume":"14","author":"Olejnik","year":"2018","journal-title":"PLoS Pathog"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.120405_bib118","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.atherosclerosis.2009.09.075","article-title":"Toll like receptor 4 in atherosclerosis and plaque destabilization","volume":"209","author":"den Dekker","year":"2010","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2025.120405_bib119","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000598","article-title":"Host defense against viral infection involves interferon mediated down-regulation of sterol biosynthesis","volume":"9","author":"Blanc","year":"2011","journal-title":"PLoS Biol"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2025.120405_bib120","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s40801-024-00430-5","article-title":"PCSK9 inhibitors and infection-related adverse events: a pharmacovigilance study using the world health organization VigiBase","volume":"11","author":"Park","year":"2024","journal-title":"Drugs Real World Outcomes"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2025.120405_bib121","doi-asserted-by":"crossref","DOI":"10.1111\/eci.14172","article-title":"Hydrocortisone cardioprotection in ischaemia\/reperfusion injury involves antioxidant mechanisms","volume":"54","author":"Escudero","year":"2024","journal-title":"Eur J Clin Invest"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2025.120405_bib122","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrrheum.2010.5","article-title":"Methotrexate--how does it really work?","volume":"6","author":"Chan","year":"2010","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2025.120405_bib123","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1002\/cpt.3394","article-title":"The effect of low-dose colchicine on the phenotype and function of neutrophils and monocytes in patients with chronic coronary artery disease: a double-blind randomized placebo-controlled cross-over study","volume":"116","author":"Tercan","year":"2024","journal-title":"Clin Pharmacol Ther"},{"issue":"14","key":"10.1016\/j.atherosclerosis.2025.120405_bib124","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1042\/CS20160090","article-title":"Colchicine therapy in acute coronary syndrome patients acts on caspase-1 to suppress NLRP3 inflammasome monocyte activation","volume":"130","author":"Robertson","year":"2016","journal-title":"Clin Sci (Lond)"},{"issue":"19","key":"10.1016\/j.atherosclerosis.2025.120405_bib125","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2025.120405_bib126","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1056\/NEJMoa2405922","article-title":"Colchicine in acute myocardial infarction","volume":"392","author":"Jolly","year":"2025","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2025.120405_bib127","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"issue":"10289","key":"10.1016\/j.atherosclerosis.2025.120405_bib128","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/S0140-6736(21)00520-1","article-title":"IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial","volume":"397","author":"Ridker","year":"2021","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.atherosclerosis.2025.120405_bib129","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.jacc.2021.02.049","article-title":"Randomized trial of Interleukin-6 receptor inhibition in patients with acute ST-Segment elevation myocardial infarction","volume":"77","author":"Broch","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2025.120405_bib130","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/eurheartj\/ehac826","article-title":"The ideal vaccine to prevent cardiovascular disease","volume":"44","author":"Frobert","year":"2023","journal-title":"Eur Heart J"},{"issue":"13","key":"10.1016\/j.atherosclerosis.2025.120405_bib131","first-page":"e771","article-title":"ACC\/AHA\/ACEP\/NAEMSP\/SCAI guideline for the management of patients with acute coronary syndromes: a report of the American college of cardiology\/american heart association joint committee on clinical practice guidelines","volume":"151","author":"Rao","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2025.120405_bib132","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC guidelines for the management of acute coronary syndromes","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur Heart J"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915025013036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915025013036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T02:25:34Z","timestamp":1773887134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915025013036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":132,"alternative-id":["S0021915025013036"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2025.120405","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The flu shot and cardiovascular Protection: Rethinking inflammation in ischemic heart disease","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2025.120405","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"120405"}}